- Home
- VRAX
as 09-06-2024 4:00pm EST
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
| Founded: | 2013 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | 17.2M | IPO Year: | 2022 |
| Target Price: | N/A | AVG Volume (30 days): | 13.1M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.36 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.60 - $9.00 | Next Earning Date: | 11-06-2024 |
| Revenue: | $156,419 | Revenue Growth: | 1727.11% |
| Revenue Growth (this year): | 5169.18% | Revenue Growth (next year): | 66.97% |
Latest Virax Biolabs Group Limited News
VRAX Breaking Stock News: Dive into VRAX Ticker-Specific Updates for Smart Investing
PR Newswire
9 days ago
Virax Biolabs to Participate at 7th European Congress of Immunology
MT Newswires
10 days ago
Sector Update: Health Care
MT Newswires
10 days ago
Virax Biolabs to Distribute Mpox Detection Kits Across Europe, GCC
PR Newswire
10 days ago
Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East
Benzinga
11 days ago
EXCLUSIVE: Virax Biolabs Inks Distribution Pact For Mpox Diagnostic Kits In Europe And Middle East
MT Newswires
15 days ago
Virax Biolabs Closes $5 Million Direct Offering of Shares
PR Newswire
15 days ago
Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares
MT Newswires
17 days ago
Virax Biolabs Group Signs Deal for $5 Million Share Offering
Compare VRAX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VRAX Virax Biolabs Group Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.